New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 14, 2014
10:11 EDTTNK, GOLD, NIHD, SQM, NVO, RDY, WAG, SBGL, NMR, DCIXOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: Diana Containerships (DCIX) downgraded to Neutral from Buy at Euro Pacific Capital... Dr. Reddy's Labs (RDY) downgraded to Underperform from Buy at BofA/Merrill... NII Holdings (NIHD) downgraded to Sell from Hold at Gabelli... Nomura (NMR) downgraded to Neutral from Outperform at Credit Suisse... Novo Nordisk (NVO) downgraded to Neutral from Buy at UBS... Randgold Resources (GOLD) downgraded to Neutral from Overweight at JPMorgan... Sibanye Gold (SBGL) downgraded to Neutral from Overweight at JPMorgan... Sociedad Quimica (SQM) downgraded to Underperform from Neutral at Credit Suisse... Teekay Tankers (TNK) downgraded at BofA/Merrill... Walgreens (WAG) downgraded to Market Perform from Outperform at Cowen.
News For DCIX;RDY;NIHD;NMR;NVO;GOLD;SBGL;SQM;TNK;WAG From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
May 21, 2015
07:08 EDTSQMSQM June volatility elevated as shares near six-year low
Subscribe for More Information
06:38 EDTNVONovo Nordisk rejects claims made by Baxter, Reuters says
Novo Nordisk (NVO) rejects claims made by Baxter (BAX) that the company used substances made by Baxter in its Novoeight haemophilia treatment, following Monday's ITC investigation announcement, reports Reuters, citing an email from Novo Nordisk. Reference Link
May 20, 2015
19:46 EDTSQMIsrael Chemicals CEO says SQM would be 'good fit,' Bloomberg reports
Subscribe for More Information
15:58 EDTSQMIsrael Chemicals CEO repeats interest in SQM, Reuters reports
Subscribe for More Information
10:26 EDTNVOJanssen acquires licence from Novo Nordisk for autoimmune disease development
Novo Nordisk (NVO) announced it has signed an agreement with Janssen Biotech (JNJ) under which Janssen will acquire an exclusive global license to further develop and commercialize a clinical program focused on therapy within autoimmune diseases. The program targets modulation of certain immune cells via a cell surface receptor, specifically the NKG2D receptor. Terms of the agreement have not been disclosed.
05:09 EDTSQMSQM reports Q1 EPS 27c, consensus 31c
Subscribe for More Information
May 18, 2015
10:01 EDTTNKOn The Fly: Analyst Initiation Summary
Subscribe for More Information
06:39 EDTTNKTeekay Tankers initiated with an Overweight at JPMorgan
Target $8.50.
May 17, 2015
17:06 EDTNMRNomura, RBS ordered to pay $806M to Fannie, Freddie, Reuters says
U.S. District Judge Denise Cote has ordered Nomura (NMR) and RBS (RBS) to pay a total of $806M for allegedly misleading Fannie Mae (FNMA) and Freddie Mac (FMCC), Reuters reported Friday, citing court proceedings and a person familiar with the matter. Reuters notes that Fannie is set to receive $26.6M from the ruling, while Freddie will receive $779.4M. Reference Link
May 15, 2015
17:15 EDTSBGLPaulson & Co. gives quarterly update on stakes
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use